Overview
Access
/time_series
data via our API — starting from the
Basic plan and above.
Description
Ib Kimyoung Co., Ltd. is a notable name in the biotechnology and pharmaceuticals sector, primarily engaged in research, development, and commercialization of innovative therapeutic solutions. The company's core mission revolves around improving patient outcomes through cutting-edge biopharmaceutical products and technologies. Ib Kimyoung Co., Ltd. has carved a niche for itself by focusing on key therapeutic areas that address critical unmet medical needs, thus playing a pivotal role in advancing healthcare solutions.
With a strong emphasis on research and development, the company invests significantly in exploring novel drug candidates and optimizing drug discovery processes. Its impact resonates across various dimensions of the healthcare industry, from providing groundbreaking treatments to enhancing the overall efficiency of healthcare delivery.
In the financial markets, Ib Kimyoung Co., Ltd. serves as a crucial entity within the biopharmaceutical landscape, contributing to the dynamism of the sector. The company's innovations not only hold the potential to transform lives but also to influence market trends, fostering growth and sustainability in the healthcare domain.
About
CEO
Mr. SeokCheol Kim
Employees
380
Address
279 Gangnam-daero
4th and 5th Floor Seocho-gu
Seoul, 137 070
4th and 5th Floor Seocho-gu
Seoul, 137 070
Phone
82 2 3456 8012
Website
Instrument type
Common stock
Sector
Financial Services
Industry
Shell Companies
Country
South Korea
MIC code
XKRX